The maker of EpiPen announced Thursday that it will help more patients pay for the lifesaving allergy injection, bowing to intense criticism from politicians, doctors and patients over the drug's soaring list price.
A key measure of corporate profits rose this spring for a second straight quarter alongside modest growth in the overall economy, though U.S.
But it's not over yet. A federal judge on Friday granted a request by Uber Technologies and its chief executive officer to put a passenger's price-fixing lawsuit against them on hold, while they appeal his refusal to let them arbitrate the dispute ...
Troubled smartphone maker BlackBerry said it would raise about $605 million by selling convertible debentures to shareholder Fairfax Financial Holdings and other investors.
Stephen L. Carter is a Bloomberg View columnist. He is a professor of law at Yale University and was a clerk to U.S. Supreme Court Justice Thurgood Marshall.